Benign Prostatic Hyperplasia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Benign Prostatic Hyperplasia stocks.

Benign Prostatic Hyperplasia Stocks Recent News

Date Stock Title
Apr 27 LLY Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Apr 26 LLY Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Apr 26 LLY How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
Apr 26 SBFM Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Apr 26 LLY Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Apr 26 BSX Here's Why Boston Scientific (BSX) is a Strong Momentum Stock
Apr 26 BSX Top 4 Health Care Stocks That May Plunge This Month
Apr 25 BSX 20 Fastest Growing Health Tech Companies in the World
Apr 25 LLY 20 Fastest Growing Health Tech Companies in the World
Apr 25 BSX Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript
Apr 25 BSX Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Apr 25 LLY Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics
Apr 25 LLY Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Apr 25 VERU Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
Apr 25 BSX Boston Scientific Corp (BSX) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and ...
Apr 25 BSX Q1 2024 Boston Scientific Corp Earnings Call
Apr 24 BSX Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars
Apr 24 BSX Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Apr 24 BSX Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
Apr 24 LLY Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.The cause is unclear. Risk factors include a family history, obesity, type 2 diabetes, not enough exercise, and erectile dysfunction. Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms. The underlying mechanism involves the prostate pressing on the urethra thereby making it difficult to pass urine out of the bladder. Diagnosis is typically based on symptoms and examination after ruling out other possible causes.Treatment options including lifestyle changes, medications, a number of procedures, and surgery. In those with mild symptoms weight loss, exercise, and decreasing caffeine intake is recommended. In those with more significant symptoms medications may include alpha blockers such as terazosin or 5α-reductase inhibitors such as finasteride. Surgical removal of part of the prostate may be carried out in those who do not improve with other measures. Alternative medicine, such as saw palmetto, does not appear to help.About 105 million people are affected globally. BPH typically begins after the age of 40. Half of males age 50 and over are affected. After the age of 80 about 90% of males are affected. Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer.

Browse All Tags